Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin

Journal of Surgical Research

Volumn 56, Issue 6, 1994, Pages 549-555

  Hadjiminas, Dimitri J ^a   McMasters, Kelly M ^a   Peyton, James C ^a   Cheadle, William G ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028318461     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1994.1088     Document Type: Article

References (42)

1. Bone, R. C, The pathogenesis of sepsis. Ann. Intern. Med. 115: 457, 1991.
2. Tracey, K. J., Lowry, S. F., Fahey, T. J., Ill, Albert, J, D-Fong, Y., Hesse, IX, Beutler, B., Manogue, K. R., Calvano, S., Wei, H., et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 164: 415, 1987.
3. Cavaillon, J. M-, Munoz, C., Fitting, C., Misset, B., andCarlet, J. Circulating cytokines: The tip of the iceberg? Circ. Shock 38: 145, 1992.
4. Hishinuma, I., Nagakawa, J., Hirota, K., Miyamoto, K., Tsuki-date, K., and Yamanaka, T. Involvement of tumor necrosis factor in development of liver injury in galactosamine sensitized mice. Hepatology 12: 1187, 1990.
5. Beutler, B. A., Milsark, I. W., and Cerami, A. Cachectin/tumor necrosis factor: Production distribution and metabolic fate in uiuo. J. Immunol. 135: 3972, 1985.
6. Keogh, C., Fong, Y., Marano, M. A., Seniuk, S., He, W., Barber, A., Minei, J. P., Felsen, D., Lowry, S. F., and Moldawer, L. L. Identification of a novel tumor necrosis factor/cachectin from the livers of burned infected rats. Arch. Surg. 125: 79, 1990.
7. Havell, E. A. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol 143: 2894, 1989.
8. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I, W., and Hariri, R. J. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470, 1986.
9. Wichterman, K. A., Baue, A. E., and Chaudry, I. H. Sepsis and septic shock: A review of laboratory models and a proposal. J. Surg. Res. 29: 189, 1980.
10. Cross, A. S., Opal, S. M., Sadoff, J. C., and Gemski, P. Choice of bacteria in animal models of sepsis. Infect. Immun. 61: 2741, 1993.
11. McMasters, K. M., and Cheadle, W. G. Regulation of macrophage TNF«, IL-ljJ, and la (I-A«) mRNA expression during peritonitis is site dependent. J. Surg. Res. 54: 426, 1993.
12. Chromczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156, 1987.
13. Chelly, J., Kaplan, J-C., Maire, P., Gautron, S., and Kahn, A. Transcription of the dystrophin gene in human muscle and nonmuscle tissues. Nature 333: 858, 1988.
14. Frye, R. A., Benz, C. C., and Liu, E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4: 1153, 1989.
15. Neubauer, A., Neubauer, B., and Liu, E. Polymerase reaction based assay to detect allelic loss in human DNA: Loss of 3-inter-feron gene in chronic myelogenous leukemia. Nucleic Acids Res. 18: 993, 1990.
16. Evers, B. M., Rady, P. L., Tyring, S. K-, Sanchez, R. L., Rajara-man, S., and Townsend, C. M., Jr. Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery 112: 211, 1992.
17. Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O’Dwyer, S., and Dinarello, C. A. Detection of circulating tumor necrosis factor after endotoxin administration, N. Engl. J. Med. 3 18: 1481, 1989.
18. Hesse, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Jr., Cerami, A., and Shires, G. T. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166: 147, 1988.
19. Zanetti, G., Heumann, D., Gerain, J., Kohler, J., Abbet, P., Barras, C., Lucas, R., and Glauser, M. P. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice, J. Immunol. 148: 1890, 1992.
20. Damas, P., Reuter, A., Gysen, P., Demorty, J., Lamy, M., and Franchimont, P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17: 975, 1989.
21. Marano, M. A., Fong, Y., Moldawer, L. L., Wei, H., Calvano, S. E., Tracey, K. J., and Barie, P. S. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol Obstet. 170: 32, 1990.
22. Martich, G. D., Danner, R. L., Ceska, M., and Suffredini, A. F, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflammatory agents. J. Exp. Med. 173: 1021, 1991.
23. fJlich, T., Guo, K., and del Castillo, J. Endotoxin induced cytokine gene expression in uiuo. Am. J. Pathol. 134: 11, 1988.
24. Ayala, A., Perrin, M. M., Wang, P., and Chaudry, I. H. Sepsis induces an early irreversible spontaneous release of hepatocellular stimulatory factor (interleukin-6) by Kuffer cells in both endotoxin tolerant and intolerant mice. J. Surg. Res. 52:635, 1992.
25. Ayala, A., Perrin, M. M., Kisala, J. M., Ertel, W., and Chaudry, I. H. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukin-1, interleukin-6 and tumor necrosis factor). Circ. Shock 36: 191, 1992.
26. Kovacs, E. J., Radzioch, D., Young, H., and Varesio, L. Differential inhibition of IL-1 and TNF-a mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141: 3101, 1988.
27. 2 suppresses tumor necrosis factor but not interleukin-ln or 0-mRNA and cell-associated bioactivity. J. Leukocyte Biol. 45: 416, 1989.
28. Dong, Z., Lu, S., and Zhang, Y. Effects of pretreatment with protein kinase C activators on macrophage activation for tumor cytotoxicity, secretion of tumor necrosis factor, and its mRNA expression. Immunobiology 179: 382, 1989.
29. Oswald, I. P., Wynn, T. A., Sher, A., and James, S. L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumoT necrosis factor a required as a costimulatory factor for interferon-y-induced activation. Proc. Natl. Acad. Sci USA 89: 8676, 1992.
30. Michie, H. R., Spriggs, D. R., Manogue, K. R., Sherman, M. L., Revhaug, A., and O’Dwyer, S. T. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280/1988.
31. Stephens, K. E., Ishizaka, A., Larrick, J. W., and Raffin, T. A, Tumor necrosis factor causes increased pulmonary permeability and edema: Comparison to septic acute lung injury. Am. Reu. Respir. Dis. 137: 1364, 1988.
32. Royall, J. A., Berkow, R. L., Beckman, J. S., Cunningham, M. K., Matalon, S., and Freeman, B. A. Tumor necrosis factor and interleukin 1 alpha increase vascular permeability. Am. J. Physiol. 257: L399, 1989.
33. Gibbs, L. S., Lai, L., and Malik, A. B. Tumor necrosis factor enhances the neutrophil dependent increase in endothelial permeability. J. Cell. Physiol. 145: 496, 1990.
34. Gamble, J. R., Harlan, J. M., Klebanoff, S. J., and Vadas, M. A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82: 8667, 1985.
35. Shalaby, M. R., Aggarwal, B. B., Rinderknect, E., Svedersky, L. P., Finkle, P. S., andPalladino, M. A., Jr. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135: 2069, 1985.
36. Berger, M., Wetzler, E. M., and Wallis, R. S. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Bfood 71: 151, 1988.
37. Nacy, C. A., Meierovics, A. I., Belesevic, M., and Green, S. J. Tumor necrosis factor: Central regulatory cytokine in the induction of macrophage antimicrohial activities. Pathobiology 59: 182, 1991.
38. Mc Masters, K. M., Peyton, J., and Cheadle, W. G. Endotoxin (LPS) resistant C3H/HeJ mice are not resistant to cecal ligation and puncture despite absence of TNF production. Proceedings, Thirteenth Annual Meeting of the Surgical Infection Society, Baltimore, MB, April 29, 1993.
39. Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., and Dinarello, C. A. Interleukin-1 induces a shock like state in rabbits: Synergism with tumor necrosis factor and the effect of cy-cloxygenase inhibition. J. Clin. Invest. 81: 1162, 1988.
40. Ayala, A., Perrin, M. M., Meldrum, D. R., Ertel, W., and Chaudry, I. H. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2: 170, 1990.
41. Wakabayashi, G., Gelfand, J. A., Jung, W. K., Connolly, R. J., Burke, J. F., and Dinarello, C. A. Staphylococcus epidermidis induces complement activation, tumor necrosis factor, and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. J. Clin. Invest. 87: 1925, 1991.
42. Timmerman, C. P., Mattsson, E., Martinez-Martinez, L., de Graaf, L., van Strijp, J. A. G., Verbrugh, H. A., Verhoef, J., and Fleer, A. Induction of release of tumor necrosis factor from human monocytes by Staphylococci and Staphylococcal peptidogly-cans. Infect. Immun. 61: 4167, 1993.